Champions Oncology
American technology company
CSBR Nasdaq
ISIN US15870P3073 SEC CIK 771856
Follow Champions Oncology
Weekly email: filings, results
Revenue, last quarter
$15.2M
+8.8% vs same quarter last year
Net income
−$426K
+8.6% vs same quarter last year
EPS, diluted
−$0.03
+0% vs same quarter last year
Operating cash flow
−$492K
−182% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY26 | $59.4M | −$1.2K |
| FY25 | $56.9M | $4.7K |
| FY24 | $50.2M | −$7.3K |
| FY23 | $53.9M | −$5.3M |
| FY22 | $49.1M | $548K |
| FY21 | $41M | $362K |
| FY20 | $32.1M | −$2.1M |
| FY19 | $27.1M | $128K |
| FY18 | $20.2M | −$1.5M |
| FY17 | - | −$6.9M |
| FY16 | - | −$10.4M |
| FY15 | - | −$13.1M |
| FY14 | - | −$7.4M |
| FY13 | - | −$6.3M |
| FY12 | - | −$8.7M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY26 | 48% | −1.9% | 0% |
| FY25 | 50.1% | 8% | 0% |
| FY24 | 41.4% | −14.7% | 0% |
| FY23 | 45.2% | −9.8% | −9.9% |
| FY22 | 51.9% | 1.2% | 1.1% |
| FY21 | 47.7% | 0.9% | 0.9% |
| FY20 | 47.1% | −6% | −6.5% |
| FY19 | - | 1% | 0.5% |
| FY18 | - | −6.7% | −7.3% |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | - | - | - |
| FY14 | - | - | - |
| FY13 | - | - | - |
| FY12 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY26 | −$5M |
| FY25 | $7M |
| FY24 | −$7M |
| FY23 | $1.1M |
| FY22 | $4.1M |
| FY21 | −$5M |
| FY20 | $685K |
| FY19 | $1M |
| FY18 | −$2.5M |
| FY17 | −$3.6M |
| FY16 | −$6.7M |
| FY15 | −$9.7M |
| FY14 | −$3.7M |
| FY13 | −$4.3M |
| FY12 | −$5.7M |
Show the numbers
| Year | Buybacks |
|---|---|
| FY26 | - |
| FY25 | $0 |
| FY24 | $634K |
| FY23 | $74K |
| FY22 | $0 |
| FY21 | - |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | - |
| FY12 | $0 |
- Champions Oncology
- Healthcare median
Show the numbers
| Year | Champions Oncology | Healthcare median |
|---|---|---|
| FY26 | 0% | −11.1% |
| FY25 | 0% | −30.6% |
| FY24 | 0% | −47% |
| FY23 | −9.9% | −58% |
| FY22 | 1.1% | −80.4% |
| FY21 | 0.9% | −71.9% |
| FY20 | −6.5% | −62.2% |
| FY19 | 0.5% | −46.3% |
| FY18 | −7.3% | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | - | −38.4% |
| FY14 | - | −35.5% |
| FY13 | - | −37.1% |
| FY12 | - | −29.1% |